{
  "url": "https://openlegislation.uk/eu-regulation-2015-1013/annex-II/annotations/1",
  "json_url": "https://openlegislation.uk/eu-regulation-2015-1013/annex-II/annotations/1.json",
  "legislation": "eur/2015/1013",
  "legislation_title": "Commission Implementing Regulation (EU) 2015/1013 of 25 June 2015 laying down rules in respect of Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and of Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2015-1013",
  "path": "annex/II/annotations/1",
  "kind": "division",
  "number": null,
  "heading": "Notes",
  "text": "1.The layout of the model is not binding.\n2.The order numbers and the text of the model are binding. The completion of the boxes marked in bold is mandatory.\n3.Details of the boxes:\nBox 1 (Registration holder): The name of the responsible officer may be added.\nBox 3 (validity/end): Specify the beginning and, where relevant, the end of validity.\nBox 4 (scheduled substances): Name of the scheduled substance as stated in the Annex, or, in the case of a mixture or a natural product, its name and the name of any scheduled substance, as stated in the Annex, contained in the mixture or in the natural product. Indicate salts, where appropriate.\nBox 4 (CN code): In addition to the CN code, the CAS number may be added.\nBox 4 (operation): Specify export, import and/or intermediary activities. In the case of import, specify whether storage, working, processing, use, usual forms of handling and/or release for free circulation, where appropriate. For operations covered by Regulation (EC) No 273/2004, specify: storage, production, manufacture, processing, trade, distribution and/or brokering.\nBox 4 (business premises): In the case of intermediary activities referred to in Article 2 of Regulation (EC) No 111/2005, the business premises need not be specified.\n4....\n5....",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch."
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Annex 2 Form notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Annex 2 Form omitted (29.6.2026) by virtue of The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(6)(b)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2015/1013/annex/II/annotations/1",
    "retrieved_at": "2026-11-01T14:46:37.262801+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}